Interleukin-10 inhibition of the progression of established collagen-induced arthritis

Arthritis and Rheumatism
M WalmsleyM Feldmann

Abstract

Interleukin-10 (IL-10) is a potent inhibitor of the proinflammatory cytokines, including tumor necrosis factor alpha and IL-1, which are considered important in the pathogenesis of rheumatoid arthritis (RA). The study was undertaken to establish whether IL-10 can ameliorate arthritis in the collagen-induced arthritis (CIA) model of RA. DBA/1 mice were immunized with bovine type II collagen in adjuvant, and treated daily after disease onset with recombinant murine IL-10 or with saline as a control. Mice were monitored for paw swelling and clinical score. Histologic analysis was also performed. IL-10 treatment of established CIA inhibited paw swelling (P < 0.0001), as well as disease progression as defined by clinical score (P < 0.0002). Cartilage destruction, as assessed histologically, was reduced in IL-10-treated mice compared with controls (P < 0.01). IL-10 suppresses established CIA, probably by inhibiting proinflammatory cytokine production. Our results, taken together with previously reported findings, indicate a potential therapeutic role for IL-10 in RA.

References

Feb 14, 1992·Biochemical and Biophysical Research Communications·F Q CunhaF Y Liew
Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·F RoussetJ Banchereau
Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R O WilliamsR N Maini
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·G J ThorbeckeM A Palladino
Mar 1, 1992·European Journal of Immunology·A O'GarraM Howard
Feb 1, 1991·The Journal of Experimental Medicine·L Thompson-SnipesD M Rennick
May 1, 1990·Annals of the Rheumatic Diseases·J Barash
Jun 1, 1994·European Journal of Immunology·O RottE Cash
Jan 1, 1995·Arthritis and Rheumatism·J J CushP E Lipsky
Oct 1, 1994·Clinical Immunology and Immunopathology·F H DurieR J Noelle
Sep 1, 1994·British Journal of Rheumatology·N A Staines, P H Wooley
May 1, 1994·The Journal of Experimental Medicine·P D KatsikisM Feldmann
Feb 1, 1994·The Journal of Experimental Medicine·F BrièreJ Banchereau
Feb 1, 1994·Clinical and Experimental Immunology·W B van den BergF A van de Loo
Jan 1, 1993·Annual Review of Immunology·K W MooreT R Mosmann
Apr 1, 1993·The Journal of Experimental Medicine·M HowardS Menon

❮ Previous
Next ❯

Citations

Dec 4, 1998·Springer Seminars in Immunopathology·C M WeyandJ J Goronzy
Dec 4, 1998·Springer Seminars in Immunopathology·J HermannF M Brennan
Oct 6, 2010·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Yajarayma J Tang-FeldmanClaire Pomeroy
May 26, 2005·Clinical Rheumatology·Andrzej PawlikMarek Drozdzik
May 17, 2006·Journal of Biomedical Science·Chi-Chen WeiMing-Shi Chang
Sep 3, 2003·Biochemical and Biophysical Research Communications·Toyoko KatayamaShinzo Oikawa
May 28, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Woo-kyoung LeeJong-sang Park
May 20, 1998·Research in Immunology·M G von Herrath
Sep 7, 2001·Current Opinion in Immunology·P C TaylorR N Maini
Dec 1, 1996·Current Opinion in Immunology·F M Brennan, M Feldmann
Jan 20, 1998·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·I LalaniA R Ahmed
Nov 28, 2002·Clinical and Experimental Immunology·I GjertssonA Tarkowski
Feb 20, 2003·The Journal of Experimental Medicine·Claudia MauriMarco Londei
Jun 13, 2002·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Heidi Schooltink, Stefan Rose-John
Apr 5, 2011·Photomedicine and Laser Surgery·Osnat FeuersteinYael Houri-Haddad
May 10, 2000·Current Opinion in Rheumatology·T PapS Gay
Oct 1, 2008·Infection and Immunity·Charles R BrownWilliam J Mitchell
May 16, 2002·Infection and Immunity·Manuela PulitiLuciana Tissi
Dec 8, 2006·Annals of the Rheumatic Diseases·Elena Gonzalez-ReyMario Delgado
Dec 1, 1999·Annals of the Rheumatic Diseases·E W St Clair

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.